إعلان
إعلان
BIOA
BioAge Labs, Inc. Common Stock
14.02
USDبرعاية
+0.10
+0.72%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
14.23
+0.21
+1.53%
تقارير أرباح BIOA
النسبة الإيجابية المفاجئة
BIOA تفوق 3 من 5 آخر التقديرات.
60%
التقرير التالي
بيانات التقرير القادم
١٨ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$1.45M
/-$0.78
التغير الضمني من Q3 25 (Revenue/ EPS)
-29.24%
/+39.29%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/-60.41%
BioAge Labs, Inc. Common Stock earnings per share and revenue
On ٠٦ نوفمبر ٢٠٢٥, BIOA reported earnings of -0.56 USD per share (EPS) for Q3 25, beating the estimate of -0.59 USD, resulting in a 6.02% surprise. Revenue reached 2.05 مليون, compared to an expected 1.06 مليون, with a 94.25% difference. The market reacted with a -2.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 المحللين forecast an EPS of -0.78 USD, with revenue projected to reach 1.45 مليون USD, implying an زيادة of 39.29% EPS, and نقصان of -29.24% in Revenue from the last quarter.
الأسئلة الشائعة
What were BioAge Labs, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, BioAge Labs, Inc. Common Stock reported EPS of -$0.56, beating estimates by 6.02%, and revenue of $2.05M, 94.25% above expectations.
How did the market react to BioAge Labs, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.81%, changed from $7.47 before the earnings release to $7.26 the day after.
When is BioAge Labs, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٨ مارس ٢٠٢٦.
What are the forecasts for BioAge Labs, Inc. Common Stock's next earnings report?
Based on 7
المحللين, BioAge Labs, Inc. Common Stock is expected to report EPS of -$0.78 and revenue of $1.45M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان